CAMBRIDGE, Mass., Oct. 31 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., announced today that it will report its financial results for the third quarter of 2007 on Tuesday, November 6, 2007 after the U.S. financial markets close.
In conjunction with the issuance of the press release, Idenix management will host a conference call at 4:30 p.m. ET on Tuesday, November 6, 2007 to discuss the company's financial results for the third quarter 2007.
To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475 International and enter passcode 21545602 or to listen to a live audio webcast of the call, go to "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. A replay of the call will also be available from 5:30 p.m. ET on November 6, 2007 until 11:30 p.m. ET on November 20, 2007. To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter passcode 21545602. An archived webcast will also be available for two weeks after the call on the Idenix website.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.
Idenix Pharmaceuticals' Contacts:
Media: Teri Dahlman (617) 995-9905
Investors: Amy Sullivan (617) 995-9838
CONTACT: Media, Teri Dahlman, +1-617-995-9905, investors, Amy Sullivan,
+1-617-995-9838, both of Idenix Pharmaceuticals, Inc.
Web site: http://www.idenix.com/
